Two sulfonamides-containing dihydropyrone derivatives as HIV protease inhibitors. 2001

J Y Lee, and S N Kim, and C K Lee, and H Park, and Y S Lee
Division of Life Sciences, Korea Institute of Science & Technology, P.O. Box 131, Cheongryang, Seoul 130-650, Korea.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011714 Pyrans Pyran
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV

Related Publications

J Y Lee, and S N Kim, and C K Lee, and H Park, and Y S Lee
August 2004, Bioorganic & medicinal chemistry letters,
J Y Lee, and S N Kim, and C K Lee, and H Park, and Y S Lee
December 2020, Biomedical reports,
J Y Lee, and S N Kim, and C K Lee, and H Park, and Y S Lee
July 2010, Bioorganic & medicinal chemistry letters,
J Y Lee, and S N Kim, and C K Lee, and H Park, and Y S Lee
July 2006, Bioorganic & medicinal chemistry letters,
J Y Lee, and S N Kim, and C K Lee, and H Park, and Y S Lee
October 2019, Journal of natural products,
J Y Lee, and S N Kim, and C K Lee, and H Park, and Y S Lee
December 2003, Bioorganic & medicinal chemistry letters,
J Y Lee, and S N Kim, and C K Lee, and H Park, and Y S Lee
October 2012, Journal of enzyme inhibition and medicinal chemistry,
J Y Lee, and S N Kim, and C K Lee, and H Park, and Y S Lee
January 2015, International journal of bioinformatics research and applications,
J Y Lee, and S N Kim, and C K Lee, and H Park, and Y S Lee
July 2011, Future medicinal chemistry,
J Y Lee, and S N Kim, and C K Lee, and H Park, and Y S Lee
December 1998, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!